Generic Clopidogrel: Has Substitution for Brand Name Plavix® Been Safe and Effective? (P5.239)
Francis M Gengo, Erica S. Westphal, Traci S. Aladeen, Kaitlin McCadden, Michelle M. Rainka, Vernice E. Bates
Abstract
Francis M Gengo, Erica S. Westphal, Traci S. Aladeen, Kaitlin McCadden, Michelle M. Rainka, Vernice E. Bates
Abstract
The purpose of this study is to determine if the introduction of generic clopidogrel bisulfate products was associated with a change in the prevalence of resistance to the antiplatelet effects of clopidogrel.
OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
The purpose of this study is to determine if the introduction of generic clopidogrel bisulfate products was associated with a change in the prevalence of resistance to the antiplatelet effects of clopidogrel.
Key concepts: Clopidogrel, Substitution (logic), Brand names, Medicine, Advertising, Pharmacology, Internal medicine, Philosophy